New research from the Sidney Kimmel Comprehensive Cancer Center – Jefferson Health has uncovered novel mechanisms by which the translocase of outer mitochondrial membrane receptor 20 (TOMM20) drives cancer aggressiveness in fibrosarcoma and chondrosarcoma.